Ryan Walsh currently serves as the Director of Mass Spectrometry at Progenesis since May 2024 and has held multiple leadership roles at SpectraPass, including Manager and Director of Research and Development since May 2021. Previous positions include Application Scientist at Shimadzu Scientific Instruments from August 2017 to May 2021, Postdoctoral Fellow at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences from September 2016 to July 2017, and Research Scientist and Service Engineer at SimulTOF Systems from August 2015 to August 2016. Ryan Walsh began a scientific career as a Scientist at ARCA biopharma, Inc. from August 2007 to August 2009. Academic credentials include a PhD in Structural Biology and Biochemistry from the University of Colorado Anschutz Medical Campus, a Master of Science in Biology from Rutgers University - Newark, and a Bachelor of Science in Biology from the New Jersey Institute of Technology.
This person is not in any teams
This person is not in any offices